Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://ballherehere.com/elementor-9601/
Are you over 18 and want to see adult content?
A complete backup of https://welovewindowslive.wordpress.com/
Are you over 18 and want to see adult content?
A complete backup of https://trikepatrol.com/model/may-capangpangan/
Are you over 18 and want to see adult content?
A complete backup of https://www.erotikgeschichten.tv/fetisch/bdsm/
Are you over 18 and want to see adult content?
A complete backup of https://ipinfo.io/AS13335
Are you over 18 and want to see adult content?
A complete backup of https://www.qingse.one/view/3024.html
Are you over 18 and want to see adult content?
A complete backup of https://tl.rulate.ru/book/5596/
Are you over 18 and want to see adult content?
A complete backup of http://www.mmvfilms.com/
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of katesplayground.com
Are you over 18 and want to see adult content?
A complete backup of polaroidgoods.com
Are you over 18 and want to see adult content?
Text
documentation-naive
documentation-naive
Register or Login
| Contact Us
Previous
Next
* 1
* 2
* 3
* 4
* 5
CURRENT CME/CE ACTIVITIES DIABETES :: ONLINE ACTIVITY Building Basal Knowledge: Establishing a Solid Foundation for Using New Options in Basal Insulin for T2DM In this engaging activity, participants will complete 3 interactive monographs featuring audio of expert faculty discussion to learn about several new longer-acting (ultralong-acting) basal insulin analogues, which are associated with lower risks of hypoglycemia than previous long-acting basal insulin analogues and may minimize barriers to optimal basal insulin therapy use. This activity will review current evidence and best practices for using basal insulin to achieve patient-centered goals in individuals with type 2 diabetes mellitus (T2DM). Participants in this activity will learn about similarities and differences among available basal insulins and consider their application in patient-centered treatment regimens. CONTINUING EDUCATION CREDIT: 1.5 _AMA PRA Category 1 Credits™_, 1.5 Continuing Nursing Education credits, or 1.25 American Academy of Family Physicians Prescribed credits. OBESITY :: ONLINE ACTIVITY Getting Real: Virtual Case Consults on the Practical Use of Weight Loss Pharmacotherapy for Chronic Obesity Management Obesity is a chronic disease associated with serious health consequences, such as cardiovascular disease and diabetes, and a fundamental goal of the medical management of obesity is weight loss for improved health. However, contributions of multiple pathogenic factors make obesity a complex disease that is unlikely to be successfully treated solely using willpower or even with a single intervention. The core approach to obesity management relies on behavioral change, reduced caloric intake, and regular physical activity; however, many people with obesity are unable to achieve and maintain sufficient weight loss to reach health goals using this approach alone. Current obesity management guidelines advocate the use of additional therapies, including weight loss pharmacotherapy, to support adherence to core interventions in individuals who struggle to lose enough weight to improve their health. Weight loss pharmacotherapy, consistent with the management of obesity as a chronic disease, should be selected based on the clinical status, needs, and preferences of the individual patient and in the context of long-term care, with frequent follow-up and adjustment as needed. The 3 virtual case studies presented in this activity provide practical, instructional scenarios that are relevant to real-world clinical situations and demonstrate patient-centered consideration of weight loss pharmacotherapy as an option for obesity management inadult patients.
DIABETES :: ONLINE ACTIVITY Reflecting on the Data Pool: Emerging Roles for SGLT1 and SGLT2Inhibition in T1DM
This interactive eBook is modeled after academic journal clubs, which feature open exchange of critical viewpoints aimed at determining the strengths, limitations, and relative value of studies in the context of ongoing research and/or practice. A brief overview describing why SGLT2 and SGLT1 inhibition are potential targets for therapy adjunct to insulin in T1DM will be followed by 3 segments, including audio panel discussion, focused on a select number of journal articles reviewed by expert faculty. Summary statements will outline the strengths and limitations of the selected publications and provide participants with faculty synthesis of and conclusions in regard to the article(s) discussed. Participants will also have the opportunity to virtually interact with the expert faculty by submitting questions via an online interface. CONTINUING EDUCATION CREDIT: 1.0 _AMA PRA Category 1 Credit™_ PAST DIABETES CME ACTIVITIES DIABETES :: MONOGRAPH CV Insulin Trials: A Clinically Focused Review of the ORIGIN and DEVOTE Cardiovascular Outcomes Trials Benchmarking Basal Insulins: A Clinically Focused Review of the ORIGIN and DEVOTE Cardiovascular Outcomes Trials This interactive monograph (eBook) summarizes findings from the landmark cardiovascular outcomes trials, ORIGIN and DEVOTE, as well as findings from other clinical trials and observational studies. The information provided in this activity is designed help healthcare professionals (HCPs) resolve some long-standing concerns they may have about insulin therapy, allowing HCPs to make fully informed, appropriate, and patient-centered decisions about current options in basal insulin therapy, especially for their patients with type 2diabetes mellitus.
CONTINUING EDUCATION CREDIT: _1.25 AMA PRA Category 1 Credits™_; 1.25 ANCC continuing nursing education credits DIABETES :: ONLINE ACTIVITY Diabetes Snap Facts: A Weekly Case-Based CME Activity _Snap Facts_ is a series of 4 short, text-based clinical “snapshots” featuring case-based questions with supporting evidence demonstrating how emerging GLP-1 receptor agonists might be implemented in different but clinically relevant patient case scenarios. Participants will receive 1 email per week, over 4 total weeks. Each case-based question will feature explanatory answers that will demonstrate how clinical evidence for emerging GLP-1 receptor agonists may apply to the patient case. Participants in this activity will receive 0.25 CE credit hour for each of the individual 4 segments, for a total of 1.0 CE credit hour. CONTINUING EDUCATION CREDIT: 1.0 _AMA PRA Category 1 Credit™_; 1.0 ANCC continuing nursing education credit DIABETES :: ONLINE ACTIVITY Insights on Emerging GLP-1 Therapies for the Treatment of T2DM: A MEDChat Special Topics Presentation This multipart, video webcast reviews important, up-to-date information on new and emerging options in glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy for the management of type 2 diabetes mellitus (T2DM). The activity consists of 4 educational modules that can be completed in any order, and participants earn credit as they complete each module. The modules provide participants with a critical review of recent safety and efficacy data for emerging GLP-1 RAs, including the potential impact on reducing cardiovascular risks and weight. Expert faculty discuss case studies that illustrate how patients with T2DM may benefit from use of these agents. CONTINUING EDUCATION CREDIT: 2.0 _AMA PRA Category 1 Credits™_; 2.0 ANCC continuing nursing education creditsDIABETES :: WEBINAR
New Options, New Insights: GLP-1 Receptor Agonist Therapy for theTreatment of T2DM
This engaging webinar activity provides diabetes-treating clinicians with valuable information on recognizing the unique characteristics of glucagon-like peptide-receptor agonists (GLP-1 RAs), including new and emerging agents in this class. The content of this webinar will be delivered in a 1-hour live broadcast and will include a real-time question-and-answer session with expert faculty available via an online web portal or by telephone. The webinar will provide a critical review of recent efficacy and safety data for new and emerging GLP-1 RAs, including the potential to reduce cardiovascular risks and weight in patients with type 2 diabetes, and offer expert perspectives regarding the agents' anticipated roles and significance in clinicalpractice.
CONTINUING EDUCATION CREDIT: 1.0 _AMA PRA Category 1 Credits™_; 1.0 ANCC continuing nursing education credits DIABETES :: ONLINE ACTIVITY Insights on Concentrated Insulins: A MEDChat Special TopicsPresentation
This multipart video webcast activity presents current, evidence-based information on topics specifically related to safe and effective use of concentrated insulins. The activity consists of 4 educational modules that can be completed in any order, and participants earn credit as they complete each module. The 4 different modules provide an overview of FDA-approved concentrated insulins, concentrated insulin use in basal regimens, concentrated insulin use in basal-prandial and pump regimens, and faculty discussions of case studies that illustrate how patients with type 2 diabetes may benefit from use of concentrated insulins. CONTINUING EDUCATION CREDIT: 2.0 _AMA PRA Category 1 Credits™_; 2.0 ANCC continuing nursing education credits DIABETES :: APPLIED PRACTICAL LEARNING Diabetes Dialogue: Pearls for Practice-Multidisciplinary Perspectives on the Management of Type 2 Diabetes and Comorbid CardiovascularDisease
Type 2 diabetes is increasingly prevalent in the United States, and cardiovascular disease (CVD) is the leading cause of mortality associated with this chronic disease. This online monograph offers valuable insights into the interrelated risks of diabetes, glycemic control, and CVD. The monograph reviews the benefits and limitations of intensive glycemic control, especially those that may impact cardiovascular (CV) health, and highlights clinically important differences in CV outcomes among major classes of agents used to treattype 2 diabetes.
CONTINUING EDUCATION CREDIT: 1.25 _AMA PRA Category 1 Credits™_; 1.25 ANCC continuing nursing education credits DIABETES :: APPLIED PRACTICAL LEARNING Virtual Case Consults Evidence-based, patient-centered care and self-management support have been shown to improve patient outcomes in the treatment of type 2 diabetes mellitus (T2DM) as a chronic, complex, progressive disease. OBESITY :: APPLIED PRACTICAL LEARNINGDiabetes Dialogue
Diabetes Dialogue
DIABETES :: APPLIED PRACTICAL LEARNING The Insulin Challenge: A Multimedia Guide to Mastering Modern InsulinTherapy
Do you consider yourself to be an expert in insulin therapy? Challenge yourself by completing 3 different levels of difficulty in this fun and interactive game! Upon entering the activity, you will start at the novice level and can advance to the next level after answering 3 of the 6 questions on that level correctly. You will face the same challenge at the intermediate level. Once you access the third and final level of difficulty, you can confirm your expertise by answering all 6 questions at the level and view feedback concerning youranswers.
DIABETES :: MONOGRAPH Diabetes Fact Finder: Helping Your Patients Get the Most Out of GLP-1Receptor Agonists
This educational activity is designed to offer practical, evidence-based considerations for appropriately applying the use of GLP-1 receptor agonists for the management of T2DM. Additionally, this online publication features expert discussions designed to provide information that can be immediately applied to clinical practice. DIABETES :: APPLIED PRACTICAL LEARNING New Developments in Insulin Therapy: Expert Answers to Your ClinicalQuestions
This highly interactive educational activity will familiarize diabetes specialists with clinical trial data focused on insulin therapy, including highlights recently reported at the American Diabetes Association 75th Scientific Sessions. Expert discussions will focus on individualizing insulin therapy according to patient comorbidities and complications, using insulin in combination with other antihyperglycemic agents to reduce hypoglycemia and weight gain, treating patients with severe insulin resistance, reviewing advances in insulin delivery technology, improving adherence to insulin therapy, and providing a scientific and clinical overview of recently approved and emerging insulins. Participants will obtain practical information to assist with translating research findings into clinicalpractice.
DIABETES :: ONLINE CASE STUDY Diabetes Stumpers: Challenging Cases in T2DM and the Role of GLP-1 RAs for Glycemic Control In this activity, participants will be given the opportunity to analyze up to 3 case studies, focusing on the role of GLP-1 RAs in T2DM. Each case study exercise will contain clinical information about GLP-1 RA therapy that can be accessed by the user at their discretion. Throughout the activity, participants will collect key information consistent with each patient’s preferences and goals, assess their current treatment T2DM regimen, and evaluate the clinical evidence for GLP-1 RA therapy in the context of the patient case. DIABETES :: ONLINE CASE STUDY Clues to Patient-Centered Hyperglycemia Management in Patients WithT2DM
This program is designed to facilitate competent patient-centereddiabetes care by:
* Reviewing current patient-centered guidelines, focusing on the management of hyperglycemia in T2DM * Considering the applicability of therapies in the context of specific clinical circumstances * Introducing information on new and emerging therapies for T2DM * Providing an opportunity for HCPs to apply their newly acquiredknowledge
DIABETES :: APPLIED PRACTICAL LEARNING GLP-1 Receptor Agonists: What’s Known? What’s New? Content for this activity is based on the live symposium “GLP-1 Receptor Agonists: What’s Known? What’s New?” that was presented as a satellite symposium at ENDO 2013 on Saturday, June 15, 2013, in San Francisco, California. DIABETES :: APPLIED PRACTICAL LEARNING Triple Play Achieving Glycemic Control Type-2 Diabetes Using InsulinGLP-1-RAs
This educational activity was recorded during a continuing medical education (CME) plenary session at the American College of Osteopathic Family Physicians Annual Convention & Scientific Seminars (ACOFP '13) on March 23, 2013, in Las Vegas, Nevada. This activity will provide a succinct overview of the application of the new guidelines and the use of insulin and GLP-1 RAs in T2DM. DIABETES :: APPLIED PRACTICAL LEARNING New Developments in Insulin Therapy: Expert Insights in Individualizing Treatment in Type 2 Diabetes This educational activity will familiarize diabetes specialists with clinical trial data pertaining to current and future insulin therapy as reported at the American Diabetes Association 72nd Scientific Sessions. By reviewing recent findings, participants will obtain practical, personalized clinical guidance to help them customize insulin regimens that are consistent with the anticipated benefits and risks for individual patients. This activity will also highlight emerging advances in insulin therapy that have the potential to impact future treatment decisions. DIABETES :: APPLIED PRACTICAL LEARNING Diabetes Mythbusters: An Investigation Into Common Misperceptions Regarding the Use of GLP-1 Receptor Agonists for Type 2 Diabetes This activity is designed to help participants recognize that GLP-1RAs can provide effective glycemic control with several nonglycemic effects that frequently align with individual patient characteristics and goals. Additionally, tools to better manage provider-patient discussions and aid patients in identifying reputable education sources will be provided. DIABETES :: MONOGRAPH Navigating the Data Stream - Consideration of Current Evidence on GLP-1 Receptor Agonists This continuing medical education (CME) activity should be of substantial interest to endocrinologists and other healthcare providers who treat individuals with diabetes. Content for this activity is based on the live symposium “Navigating the Data Stream: An Expert-Led Journal Club Focused on GLP-1 Receptor Agonist Studies in Type 2 Diabetes,” which was presented as a satellite symposium at ENDO 2012 on Sunday, June 24, 2012, in Houston, Texas. DIABETES :: APPLIED PRACTICAL LEARNING Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice This activity and the live CME symposium on which it is based are supported by an educational grant from Novo Nordisk, Inc. The live symposium, “Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice,”—presented Thursday, October 18, 2012, at the American Academy of Family Physicians (AAFP) Scientific Assembly—was sponsored by the Institute for Medical and Nursing Education, Inc (IMNE). This event was not part of the official AAFP Scientific Assembly. DIABETES :: APPLIED PRACTICAL LEARNING Insulin Therapy is Still Hot and Getting Hotter The evidence base surrounding insulin therapy in diabetes is changing rapidly. Expert discussion of current studies of investigational insulins, treatment regimens, and delivery technologies will help participants gain perspective on how potential new options might be used to individualize therapy. DIABETES :: WEBCAST SERIES AADE Recorded Webinars Available whenever you are, AADE Recorded Webinars are the flexible resource that will keep your expertise up-to-the-minute and your busy schedule on track. Sign up now, then participate at your convenience from the comfort of your office or home. DIABETES :: APPLIED PRACTICAL LEARNING Hot Topics - New Developments in Insulin Therapy Insulin therapy is the most vital and efficacious treatment for diabetes, yet it remains the most complex. Current issues in insulin therapy include setting appropriate individual glycemic targets, using currently available insulins more effectively and safely, and using insulin in combination with incretin therapies. Recent research has paradoxically clarified some of these issues, but further complicated others. The future of insulin therapy will offer additional opportunities to individualize therapy, as investigations are designed to explore various strategies to deliver insulin in a more perfectly physiologic manner, including new types of insulin analogues, new routes of administration, and new delivery technologies. This activity will discuss recent findings pertaining to both the present and futureof insulin therapy.
DIABETES :: APPLIED PRACTICAL LEARNING Build A Case in Type 2 Diabetes: Your Patients and GLP-1 ReceptorAgonist Therapy
This CME activity is intended to increase understanding of the characteristics of GLP-1 RAs, including efficacy, nonglycemic effects, and safety profiles, relative to other antidiabetic agents, and to provide information to facilitate their appropriate and successful use in individualized treatment regimens for patients with T2D. The activity is based on a live satellite symposium conducted during the 2011 American Academy of Family Physicians (AAFP) Scientific Assembly. Case scenarios, developed according to input from participants in the live symposium, provide the framework for discussing GLP-1 RAs in the context of caring for patients with T2D. DIABETES :: APPLIED PRACTICAL LEARNING Building A Solid Foundation in Diabetes: The Nuts and Bolts of InsulinTherapy
In this activity, you will be asked to consider a patient likely to be encountered in family practice. The case will begin at a basic level and become more complex throughout the activity, as new factors are added requiring additional consideration and treatment adjustments. This approach will permit piecewise acquisition of knowledge within the framework of a complete case using a jigsaw-puzzle format, engaging you in real-time learning with immediate clinical applicability. You will be able to submit and compare your responses to other participants. DIABETES :: APPLIED PRACTICAL LEARNING No Sugar Coating Required: Real-Life Application of Incretin-Based Therapies in Type 2 Diabetes Incretin-based therapies, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors, provide effective glycemic control in type 2 diabetes (T2D), paired with beneficial nonglycemic effects on weight, lipids, and bloodpressure.
This unique program will highlight the comparative effectiveness and safety of these agents, appropriate patient selection, timely treatment initiation, and common barriers to glycemic control through the use of a simulated patient. This activity is intended for osteopathic physicians who treatpatients with T2D.
DIABETES :: ONLINE ACTIVITY Hot Seat Discussion on GLP-1 Receptor Agonists ...Your QuestionsAnswered
Recent clinical trials have demonstrated the therapeutic efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) at different stages of diabetes progression, and exploratory studies suggest the potential for therapeutic uses other than glycemic control in patients with type 2 diabetes mellitus (T2DM). This continuing medical education (CME/CE) symposium will focus on hot topics arising from the most current information relevant to GLP-1 RAs. This activity includes an introductory segment followed by 8 "hot topic" discussions, each consisting of comparative answer polling questions; a short written excerpt of relevant, corresponding clinical data; and audio clips of the faculty roundtable discussion derived from questions received during the live activity. DIABETES :: APPLIED PRACTICAL LEARNING Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy This activity, and the live symposium on which it is based, were supported by an education grant from Novo Nordisk, Inc. The live symposium, “Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy,” presented Thursday, March 17, 2011, at the American College of Osteopathic Family Physicians’ (ACOFP) 48th Annual Convention & Exhibition in San Antonio, Texas, was sponsored by the ACOFP and developed by the Institute for Medical and Nursing Education. DIABETES :: ONLINE CASE STUDY Identifying the Pathway to Successful Patient Care: Practical Implementation of Incretin-Based Therapies in Type 2 Diabetes This activity is intended for family physicians and other HCPs who treat patients with T2D. DIABETES :: WEBCAST SERIES Prospects for GLP-1 Receptor Agonists: When, Who, and How to Treat This activity is intended for physicians, nurses, nurse practitioners, physician assistants, certified diabetes educators, and other HCPs who care for patients with T2DM and manage the complications related tothis disease.
DIABETES :: ONLINE CASE STUDY Optimizing Insulin Therapy: A Case-based Activity This activity is intended for physicians, diabetes educators, nurses and other healthcare professionals who treat patients with diabetes. DIABETES :: MONOGRAPH Peak Issues 4: Clinical Use Of Incretin-Based Therapies To Treat Type2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patientswith 2 diabetes.
DIABETES :: MONOGRAPH Peak Issues 3: Clinical Use Of Incretin-Based Therapies To Treat Type2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target. DIABETES :: WEBCAST SERIES Evolving Landscape of Incretin-Based Therapies Webcast Type 2 diabetes is a progressive disease that often requires treatment intensification using several therapeutic agents. Incretin-based therapies address numerous pathophysiologic defects in type 2 diabetes with limited side effects.This content will discuss incretin-based therapies in depth, from pathophysiologic effects to clinical use, and will incorporate interactive questions whereby you can evaluate your answers against those of your colleagues, along with a concluding faculty panel discussion. DIABETES :: ONLINE CASE STUDY Cases in Practice: Incretin-Based Therapies for Common PatientEncounters
This activity is composed of 3 interactive case studies which explore options for the clinical use of incretin-based therapies in diverse clinical scenarios. Because each case study examines different aspects of diabetes care, completion of all 3 is expected to provide a broader perspective regarding the use of the 2 available classes of incretin-based therapies. DIABETES :: MONOGRAPH Peak Issues 2: Clinical Use Of Incretin-Based Therapies To Treat Type2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target. DIABETES :: MONOGRAPH Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes Incretin-based therapies, with their unique pathophysiology, have rapidly evolved into a therapeutic option that can fill this role. The symposium content, enhanced with an audience response system (ARS) and a case-based panel discussion, will concentrate on various critical aspects of successful type 2 diabetes disease management. Patient selection and strategies for advancement to incretin-based therapies are among the topics that will be discussed. DIABETES :: MONOGRAPH Peak Issues: Clinical Use Of Incretin-Based Therapies To Promote PPG Control In Type 2 Diabetes This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target. DIABETES :: MONOGRAPH Incretin Insider: incretin Mimetics 2008 in Review A wealth of new data on incretin mimetics were released and published in 2008. This publication will summarize these key findings and offer insight into the clinical utility of incretin mimetics. This activity is intended for endocrinologists as well as other physicians and healthcare professionals treating patients with type 2 diabetes. DIABETES :: WEBCAST SERIES Managing FPG and PPG With Incretin-Based Therapies: A TherapeuticDouble Play
In the area of clinical management of diabetes, an urgent and ongoing need for appropriate treatment remains. In order to effectively manage this widespread disease, clinical professionals need to fully understand diabetes and its treatment options. DIABETES :: ONLINE CASE STUDY The Amazing Race to Tight Glycemic Control Interactive Online CME Cases from IMP's ADA 2008 Symposium entitled 'THE AMAZING RACE to Tight Glycemic Control: Managing Complex Patients With Insulin Analogs' DIABETES :: WEBCAST SERIES ADA Summary Conference Report 2008 In Conjunction with the 2008 American Diabetes Association's 68th Annual Scientific Sessions this educational activity is designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with type 2 diabetes. OBESITY :: APPLIED PRACTICAL LEARNING Cardiometabolic Risk Reduction in the Metabolic Syndrome and Type 2Diabetes
This activity was developed for physicians, nurses, and pharmacists involved in the management of patients with obesity and cardiometabolic risk factors. About Us | Terms of Use| Privacy Statement
| Disclaimer
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0